Indexed with PubMed and Science Citation Index (E) 
Users online: 6925 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (44 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded217    
    Comments [Add]    

Recommend this journal

Year : 2004  |  Volume : 70  |  Issue : 1  |  Page : 61

Recent advances in dermatology

How to cite this article:
Valia R G. Recent advances in dermatology . Indian J Dermatol Venereol Leprol 2004;70:61

How to cite this URL:
Valia R G. Recent advances in dermatology . Indian J Dermatol Venereol Leprol [serial online] 2004 [cited 2021 Jan 19];70:61. Available from:

Editor: Dr. Sanjay Ghosh, Jaypee, New Delhi.
Price: Rs. 250/- Pages: 258.

Any book on recent advances should give new insights into the etiology of a disease or acquaint us with new diagnostic tools or methods of management. Measured by these criteria, this volume passes the muster. It is indeed useful to a busy practicing dermatologist and to a post-graduate student.

However, as with any multi-author book, some chapters are much better written than others. There is comparatively little discussion on the treatment of cutaneous tuberculosis. In the chapter on leukocytoclastic vasculitis, only one paragraph is devoted to the treatment. The chapter, “Emergencies in pediatric dermatology” includes too many entities in a few pages and gives the clinical description of each, while only briefly discussing their management. The treatment of pemphigus in children lists methotrexate, cyclophosphamide, azathioprine, gold and cyclosporine in one sentence. Advice to use talc and hydrocolloid dressings for pemphigus is debatable. Oral ketoconazole, advised for treating neonatal candidiasis, has been largely supplanted by the newer triazoles because of the fear of hepatotoxicity of ketoconazole. The chapter of STDs would have benefited by a section dealing with the modified clinical manifestations of STDs associated with HIV infection.

I congratulate the editor and his colleagues for this publication and hope that they will bring out many more updates like the present one to give us glimpses of the expanding frontiers of dermatology. 


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow